1. 溶瘤病毒疗法的研究现状与展望[10] ZENDEDEL E, ATKIN S L, SAHEBKAR A. Use of stem cells as carriers of oncolytic viruses for cancer treatment[J]. J Cell Physiol, 2019, 234...
2. 茶中多酚类化合物抗流感病毒的研究进展[34] JARIWALLA R J, ROOMI M W, GANGAPURKAR B, et al. Suppression of influenza A virus nuclear antigen production and neuraminidase activity by a ...
3. ccgpIK04dbivHEVI0DlSm0h76VaajspuzeenJT2mVgK7x+IfVyLgjxVdO0Gs76tsMMuingYNPjd6HVSzLMkWRMO1VU7nmsFmUKaRXIh50scA4sdY5qW0x7WIMKdWHuAxre8c/ybSRwCVLevA...
4. ggzyjyzx.tl.gov.cn/tlsggzy/ReadAttachFile.aspx?GongGaoType=...bXp8e1AqOJ3bHb6EcgbIeDQS6HSP9la0PQM3lxHfeWzU0yeWk7tLDQnLxihfl2fsP39DAn+axKAr07PNzqQLBWU72aM8b88JUIFCoTwR98DHz3MfKQmncs3sD6DXxzPyo/BCgzk5HUCtpR...
5. Molecular classification of oral cancer by cDNA microarrays...PRKAR2A F‐5′‐AAAGGATGGGCAGAGGTTCA‐3′/R‐5′‐GGGCCTTCAGAAGCAAAGTG‐3′ ANP32A F‐5′‐GGGACATTCCCCATCTCTCA‐3′/R‐5′‐CCCACCACCATCTGTGA...
6. Molecular classification of oral cancer by cDNA microarrays...Hence, we selected 6 genes (CIDEB, PRKAR2A, ANP32A, SMARCC2, CLDN1 and GALNT6) with the lowest QE scores (QE < 0.1) for validation by ...
KAR-035